Teva Completes the Purchase of 4.61 Percent Interest in Mylan N.V.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- Oil falls ahead of US announcement of new sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq slip as Iran tensions test markets in high-stakes week
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
- Hungarian Gripen jet crashes, no injuries reported, PM Magyar says
Teva Pharma (TEVA) Completes Acquisition of 4.6% Mylan (MYL) Stake
June 19, 2015 8:35 AM EDTTeva Pharma (NYSE: TEVA) announced that it has completed the purchase of 4.61 percent of all outstanding shares of Mylan N.V. (Nasdaq: MYL), which will enable Teva to commence proceedings before the Dutch Enterprise Chamber, should it become... More
